We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bio Rad Laboratories Inc | NYSE:BIO.B | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 279.91 | 279.05 | 279.05 | 279.05 | 5 | 22:00:00 |
|
|
|
Delaware
|
|
94-1381833
|
(State or other jurisdiction of incorporation)
|
|
(I.R.S. Employer Identification No.)
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
:
|
|
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
|
|
|
|
Emerging growth company
¨
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
|
|
|
|
|
|
Securities registered pursuant to Section 12(b) of the Act:
|
||||
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Class A Common Stock, Par Value $0.0001 per share
|
|
BIO
|
|
New York Stock Exchange
|
Class B Common Stock, Par Value $0.0001 per share
|
|
BIOb
|
|
New York Stock Exchange
|
ITEM 5.07
|
Submission of Matters to a Vote of Security Holders.
|
|
|
Bio-Rad Laboratories, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 29, 2019. The matters voted upon at the meeting and the results of those votes are set forth below.
|
|
|
|
BIO-RAD LABORATORIES, INC.
|
|
|
|
|
|
|
Date:
|
May 2, 2019
|
|
By:
|
/s/ Timothy S. Ernst
|
|
|
|
|
Timothy S. Ernst
|
|
|
|
|
Executive Vice President, General Counsel and Secretary
|
1 Year Bio Rad Laboratories Chart |
1 Month Bio Rad Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions